Hi, I'm Dr. Rajendra Kaimal

Dr. Rajendra Kaimal, aged 47 years, is the Executive Director of Arch Pharmalabs Limited and was first appointed as an Additional Director in our Company on November 1, 2003. He holds a bachelor’s degree in commerce from the University of Mumbai. He has completed his master’s in management studies from Narsee Monjee Institute of Management Studies, Mumbai, and is a Cost Accountant from the Institute of Cost and Works Accountants of India.
Dr. Rajendra Kaimal has been accorded with an Honorary Doctorate in Business Management by Dr. APJ Abdul Kalam University and Research Centre. The honor has been conferred for his exemplary contribution in helping the organization in its journey toward a global transformation.

Experience in the Pharmaceutical Industry

25 Years of Experience in the Pharmaceutical Industry

He was one of the promoters of Arch Commerz Private Limited, which reverse-merged into our Company pursuant to the Scheme of Rehabilitation, and has over 25 years of experience in the pharmaceutical industry. He is overall in charge of overseeing the commercial operations of our Company including purchase and export functions. He is also responsible for day-to-day coordination between all the manufacturing facilities of our Company.

Dynamic Global Business of Arch Pharmalabs Limited

Seeking greater challenges, his strategies were founded on the belief that extraordinary success is brought about by extraordinary leadership. Dr. Rajendra Kaimal has enjoyed a wide range of top-level decision-making exposure and risk-taking experience in the dynamic global business of Arch Pharmalabs Limited for over two and half decades.For over two and a half decades, Dr. Rajendra Kaimal has had extensive top-level decision-making and risk-taking experience in Arch Pharmalabs Limited's dynamic global business.

The Power of Ayurvedic Medicine

He says just like Indians have discovered medicinal power of plants and herbs and named it Ayurveda, there is Chinese Traditional Medicine which offers relief to patients suffering from various health issues. He adds that even after a lot of attempts, China has not been able to market its CTM (Chinese Traditional Medicine) to the world.

Lifesaving drugs at Arch Pharmalabs Ltd

He says the success of developing several critical and lifesaving drugs at Arch Pharmalabs Ltd has made him a big believer in the India growth story. Sharing the success of the company in developing drugs he states that the company has developed drugs related to curing cardiac issues, anti-cancer, anti-retro viral (for AIDS) and others.